from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3571/kshB

LFCtreatmentdescriptionclass of inhibitor

0.756

Amikacinug/mL Amikacintranslation

0.099

Cap5-10ug/mL Capreomycintranslation

0.134

Rox10-50 ug/mL Roxithromycintranslation

1.613

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.132

Rif0.2-5ug/mL Rifampicintranscription

0.059

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.232

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.361

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.840

CPZ10-50 ug/mL Chlorpromazinerespiration

0.180

Clofazimine10-13 ug/mL Clofaziminerespiration

0.223

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.339

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.089

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.373

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.251

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.786

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.925

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.074

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.282

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.071

Nigericin50 uM Nigericinrespiration

0.497

TRC10-150 ug/mL Triclosanrespiration

-0.080

TRZ10-25 ug/mL Thioridazinerespiration

1.424

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.550

menadione6-10 ug/mL Menadionerespiration

2.430

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.283

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.122

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.678

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.911

NRP_1Non-replicating persistence stage 1dosRassociated

-0.483

Amp0.2mg/mL AmpicillincellWall

-0.104

Cephalexin20-100 ug/mL CephalexincellWall

0.872

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.642

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.380

EMB10-20 ug/mL EthambutolcellWall

-0.459

Eta12-40 ug/mL EthionamidecellWall

-0.432

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.399

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.250

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.253

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.228

BZA0.12 mg/mL BenzamidearomaticAmides

-0.574

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.291

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.529

H2O24 mM hydrogen peroxideDNAdamaging

-0.333

Levo10 ug/mL LevofloxacinDNAdamaging

-0.196

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.691

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.485

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.277

UVUV-irradiationDNAdamaging

1.404

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.611

Antimycin12.5-50 ug/mL Antimycin A?

-0.146

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.397

PA_110-50 ug/mL Antitubercular compound PA-1?

0.300

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.137

PA8240.2-2 ug/mL PA-824?

-0.150

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.637

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.198

Verapamil50 uM Verapamil?

-0.332

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.378

methoxatin10-20 ug/mL Methoxatin?